{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:40:26Z","timestamp":1793252426854,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-17\\u2013532882"],"award-info":[{"award-number":["AARG-17\\u2013532882"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023259","name":"Fondation Segr\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006388","name":"H\u00f4pitaux Universitaires de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbi.2025.106138","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T06:17:04Z","timestamp":1760336224000},"page":"106138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Microbiota-gut-brain axis dysregulation in Alzheimer\u2019s disease and its modulation through probiotic supplementation"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-2988","authenticated-orcid":false,"given":"Moira","family":"Marizzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Alboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Vito","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peppino","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Luongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Saleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Begni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.106138_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1032494","article-title":"Effects of probiotic supplements on cognition, anxiety, and physical activity in subjects with mild and moderate Alzheimer's disease: a randomized, double-blind, and placebo-controlled study","volume":"14","author":"Akhgarjand","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbi.2025.106138_b0010","doi-asserted-by":"crossref","unstructured":"Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C.,\u2026Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7(3), 270-279. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008.","DOI":"10.1016\/j.jalz.2011.03.008"},{"issue":"6","key":"10.1016\/j.bbi.2025.106138_b0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1212\/WNL.56.6.737","article-title":"Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T","volume":"56","author":"Antuono","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2025.106138_b0020","doi-asserted-by":"crossref","unstructured":"Asaoka, D., Xiao, J., Takeda, T., Yanagisawa, N., Yamazaki, T., Matsubara, Y.,\u2026Sato, N. (2022). Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis, 88(1), 75-95.","DOI":"10.3233\/JAD-220148"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2025.106138_b0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12031-002-0036-0","article-title":"Development of indole-3-propionic acid (OXIGON) for Alzheimer's disease","volume":"19","author":"Bendheim","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2025.106138_b0030","doi-asserted-by":"crossref","unstructured":"Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A.,\u2026Caporaso, J. G. (2019). Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol, 37(8), 852-857. https:\/\/doi.org\/10.1038\/s41587-019-0209-9.","DOI":"10.1038\/s41587-019-0209-9"},{"key":"10.1016\/j.bbi.2025.106138_b0035","doi-asserted-by":"crossref","unstructured":"Bonfili, L., Cecarini, V., Berardi, S., Scarpona, S., Suchodolski, J. S., Nasuti, C.,\u2026Eleuteri, A. M. (2017). Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep, 7(1), 2426. https:\/\/doi.org\/10.1038\/s41598-017-02587-2.","DOI":"10.1038\/s41598-017-02587-2"},{"key":"10.1016\/j.bbi.2025.106138_b0045","doi-asserted-by":"crossref","unstructured":"Cammann, D., Lu, Y., Cummings, M. J., Zhang, M. L., Cue, J. M., Do, J.,\u2026Chen, J. (2023). Genetic correlations between Alzheimer's disease and gut microbiome genera. Sci Rep, 13(1), 5258. https:\/\/doi.org\/10.1038\/s41598-023-31730-5.","DOI":"10.1038\/s41598-023-31730-5"},{"key":"10.1016\/j.bbi.2025.106138_b0050","doi-asserted-by":"crossref","unstructured":"Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C.,\u2026Group, I.-F. (2017). Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging, 49, 60-68. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.019.","DOI":"10.1016\/j.neurobiolaging.2016.08.019"},{"key":"10.1016\/j.bbi.2025.106138_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105745","article-title":"Butyrate as a potential therapeutic agent for neurodegenerative disorders","volume":"176","author":"Chakraborty","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbi.2025.106138_b0060","doi-asserted-by":"crossref","unstructured":"Chang, C. H., Lin, C. H., Liu, C. Y., Huang, C. S., Chen, S. J., Lin, W. C.,\u2026Lane, H. Y. (2021). Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches. J Psychopharmacol, 35(3), 265-272. https:\/\/doi.org\/10.1177\/0269881120972331.","DOI":"10.1177\/0269881120972331"},{"key":"10.1016\/j.bbi.2025.106138_b0065","doi-asserted-by":"crossref","unstructured":"Chen, Z., Wang, Z., Li, D., Zhu, B., Xia, Y., Wang, G.,\u2026Wang, C. (2022). The gut microbiota as a target to improve health conditions in a confined environment. Front Microbiol, 13, 1067756. https:\/\/doi.org\/10.3389\/fmicb.2022.1067756.","DOI":"10.3389\/fmicb.2022.1067756"},{"key":"10.1016\/j.bbi.2025.106138_b0070","doi-asserted-by":"crossref","unstructured":"Chouraki, V., Preis, S. R., Yang, Q., Beiser, A., Li, S., Larson, M. G.,\u2026Seshadri, S. (2017). Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study. Alzheimers Dement, 13(12), 1327-1336. https:\/\/doi.org\/10.1016\/j.jalz.2017.04.009.","DOI":"10.1016\/j.jalz.2017.04.009"},{"key":"10.1016\/j.bbi.2025.106138_b0075","doi-asserted-by":"crossref","unstructured":"Chui, Z. S. W., Chan, L. M. L., Zhang, E. W. H., Liang, S., Choi, E. P. H., Lok, K. Y. W.,\u2026Kwok, J. Y. Y. (2024). Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis. Sci Rep, 14(1), 9558. https:\/\/doi.org\/10.1038\/s41598-024-59250-w.","DOI":"10.1038\/s41598-024-59250-w"},{"issue":"31","key":"10.1016\/j.bbi.2025.106138_b0080","doi-asserted-by":"crossref","first-page":"21937","DOI":"10.1074\/jbc.274.31.21937","article-title":"Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid","volume":"274","author":"Chyan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2025.106138_b0085","article-title":"Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: a Door to the Body","volume":"12\u20132021","author":"Cristofori","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.106138_b0090","doi-asserted-by":"crossref","unstructured":"Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M.,\u2026Dinan, T. G. (2019). The Microbiota-Gut-Brain Axis. Physiol Rev, 99(4), 1877-2013. https:\/\/doi.org\/10.1152\/physrev.00018.2018.","DOI":"10.1152\/physrev.00018.2018"},{"issue":"4","key":"10.1016\/j.bbi.2025.106138_b0095","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.18632\/aging.102810","article-title":"Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment - a meta-analysis of randomized controlled trials","volume":"12","author":"Den","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbi.2025.106138_b0100","doi-asserted-by":"crossref","unstructured":"Fei, Y., Wang, R., Lu, J., Peng, S., Yang, S., Wang, Y.,\u2026Li, M. (2023). Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment. Geriatr Nurs, 51, 167-175. https:\/\/doi.org\/10.1016\/j.gerinurse.2023.03.006.","DOI":"10.1016\/j.gerinurse.2023.03.006"},{"issue":"3","key":"10.1016\/j.bbi.2025.106138_b0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.bbi.2025.106138_b0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-170485","article-title":"Kynurenine Pathway Metabolites in Alzheimer's Disease","volume":"60","author":"Giil","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2025.106138_b0115","doi-asserted-by":"crossref","unstructured":"Grabrucker, S., Marizzoni, M., Silajd\u017ei\u0107, E., Lopizzo, N., Mombelli, E., Nicolas, S.,\u2026Nolan, Y. M. (2023). Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis. Brain, 146(12), 4916-4934. https:\/\/doi.org\/10.1093\/brain\/awad303.","DOI":"10.1093\/brain\/awad303"},{"issue":"2","key":"10.1016\/j.bbi.2025.106138_b0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/19490976.2016.1138197","article-title":"Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice","volume":"7","author":"Grazul","year":"2016","journal-title":"Gut Microbes"},{"issue":"24","key":"10.1016\/j.bbi.2025.106138_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/nu16244405","article-title":"Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity","volume":"16","author":"Gruenbaum","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2025.106138_b0130","doi-asserted-by":"crossref","unstructured":"Haran, J. P., Bhattarai, S. K., Foley, S. E., Dutta, P., Ward, D. V., Bucci, V., & McCormick, B. A. (2019). Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio, 10(3). https:\/\/doi.org\/10.1128\/mBio.00632-19.","DOI":"10.1128\/mBio.00632-19"},{"issue":"1","key":"10.1016\/j.bbi.2025.106138_b0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00001756-200201210-00041","article-title":"Proton MR spectroscopic study at 3 Tesla on glutamate\/glutamine in Alzheimer's disease","volume":"13","author":"Hattori","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbi.2025.106138_b0140","doi-asserted-by":"crossref","unstructured":"Hsu, Y. C., Huang, Y. Y., Tsai, S. Y., Kuo, Y. W., Lin, J. H., Ho, H. H.,\u2026Sun, Y. (2023). Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer's Dementia: A 12-Week Randomized, Double-Blind Active-Controlled Study. Nutrients, 16(1). https:\/\/doi.org\/10.3390\/nu16010016.","DOI":"10.3390\/nu16010016"},{"key":"10.1016\/j.bbi.2025.106138_b0145","doi-asserted-by":"crossref","unstructured":"Huang, Y. L., Lin, C. H., Tsai, T. H., Huang, C. H., Li, J. L., Chen, L. K.,\u2026Wang, P. N. (2021). Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's Disease. Int J Mol Sci, 22(20). https:\/\/doi.org\/10.3390\/ijms222010903.","DOI":"10.3390\/ijms222010903"},{"key":"10.1016\/j.bbi.2025.106138_b0150","doi-asserted-by":"crossref","unstructured":"Hwang, I. K., Yoo, K. Y., Li, H., Park, O. K., Lee, C. H., Choi, J. H.,\u2026Won, M. H. (2009). Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus. J Neurosci Res, 87(9), 2126-2137. https:\/\/doi.org\/10.1002\/jnr.22030.","DOI":"10.1002\/jnr.22030"},{"key":"10.1016\/j.bbi.2025.106138_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.bbi.2025.106138_b0160","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3233\/JAD-200436","article-title":"Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease","volume":"76","author":"Kaur","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2025.106138_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118627","article-title":"Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease","volume":"264","author":"Kesika","year":"2021","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.bbi.2025.106138_b0170","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00702-015-1381-9","article-title":"Elevated fecal calprotectin in patients with Alzheimer's dementia indicates leaky gut","volume":"122","author":"Leblhuber","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"12","key":"10.1016\/j.bbi.2025.106138_b0175","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1389200219666180813144834","article-title":"Probiotic Supplementation in patients with Alzheimer's Dementia - an Explorative intervention Study","volume":"15","author":"Leblhuber","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbi.2025.106138_b0180","doi-asserted-by":"crossref","unstructured":"Li, L., Yang, C., Jia, M., Wang, Y., Zhao, Y., Li, Q.,\u2026Liu, Z. (2024). Synbiotic therapy with Clostridium sporogenes and xylan promotes gut-derived indole-3-propionic acid and improves cognitive impairments in an Alzheimer's disease mouse model. Food Funct, 15(15), 7865-7882. https:\/\/doi.org\/10.1039\/d4fo00886c.","DOI":"10.1039\/D4FO00886C"},{"key":"10.1016\/j.bbi.2025.106138_b0185","doi-asserted-by":"crossref","unstructured":"Ling, Z., Zhu, M., Yan, X., Cheng, Y., Shao, L., Liu, X.,\u2026Wu, S. (2020). Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease. Front Cell Dev Biol, 8, 634069. https:\/\/doi.org\/10.3389\/fcell.2020.634069.","DOI":"10.3389\/fcell.2020.634069"},{"key":"10.1016\/j.bbi.2025.106138_b0190","doi-asserted-by":"crossref","unstructured":"Ma, Q., Li, Y., Wang, J., Li, P., Duan, Y., Dai, H.,\u2026Zhao, B. (2020). Investigation of gut microbiome changes in type 1 diabetic mellitus rats based on high-throughput sequencing. Biomed Pharmacother, 124, 109873. https:\/\/doi.org\/10.1016\/j.biopha.2020.109873.","DOI":"10.1016\/j.biopha.2020.109873"},{"issue":"10","key":"10.1016\/j.bbi.2025.106138_b0195","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae041","article-title":"Ketamine Prevents Inflammation-Induced Reduction of Human Hippocampal Neurogenesis via Inhibiting the production of Neurotoxic Metabolites of the Kynurenine Pathway","volume":"27","author":"Mandal","year":"2024","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2025.106138_b0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/13872877251337773","article-title":"Circulating short chain fatty acids in Alzheimer's disease: a cross-sectional observational study","volume":"106","author":"Marizzoni","year":"2025","journal-title":"Journal of Alzheimer's Disease : JAD"},{"key":"10.1016\/j.bbi.2025.106138_b0205","doi-asserted-by":"crossref","unstructured":"Marizzoni, M., Cattaneo, A., Mirabelli, P., Festari, C., Lopizzo, N., Nicolosi, V.,\u2026Frisoni, G. B. (2020). Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease. J Alzheimers Dis, 78(2), 683-697.","DOI":"10.3233\/JAD-200306"},{"key":"10.1016\/j.bbi.2025.106138_b0210","doi-asserted-by":"crossref","unstructured":"Marizzoni, M., Gurry, T., Provasi, S., Greub, G., Lopizzo, N., Ribaldi, F.,\u2026Cattaneo, A. (2020). Comparison of Bioinformatics Pipelines and Operating Systems for the Analyses of 16S rRNA Gene Amplicon Sequences in Human Fecal Samples. Front Microbiol, 11, 1262. https:\/\/doi.org\/10.3389\/fmicb.2020.01262.","DOI":"10.3389\/fmicb.2020.01262"},{"key":"10.1016\/j.bbi.2025.106138_b0215","doi-asserted-by":"crossref","unstructured":"Marizzoni, M., Mirabelli, P., Mombelli, E., Coppola, L., Festari, C., Lopizzo, N.,\u2026Frisoni, G. B. (2023). A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers. Alzheimers Res Ther, 15(1), 101. https:\/\/doi.org\/10.1186\/s13195-023-01218-5.","DOI":"10.1186\/s13195-023-01218-5"},{"key":"10.1016\/j.bbi.2025.106138_b0220","doi-asserted-by":"crossref","unstructured":"Mathewson, N. D., Jenq, R., Mathew, A. V., Koenigsknecht, M., Hanash, A., Toubai, T.,\u2026Reddy, P. (2016). Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol, 17(5), 505-513. https:\/\/doi.org\/10.1038\/ni.3400.","DOI":"10.1038\/ni.3400"},{"key":"10.1016\/j.bbi.2025.106138_b0225","doi-asserted-by":"crossref","unstructured":"McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H.,\u2026Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7(3), 263-269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"10.1016\/j.bbi.2025.106138_b0230","doi-asserted-by":"crossref","unstructured":"Meier-Stephenson, F. S., Meier-Stephenson, V. C., Carter, M. D., Meek, A. R., Wang, Y., Pan, L.,\u2026Weaver, D. F. (2022). Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites. Alzheimers Dement (N Y), 8(1), e12283. https:\/\/doi.org\/10.1002\/trc2.12283.","DOI":"10.1002\/trc2.12283"},{"key":"10.1016\/j.bbi.2025.106138_b0235","doi-asserted-by":"crossref","unstructured":"Morimoto, S., Takao, M., Hatsuta, H., Nishina, Y., Komiya, T., Sengoku, R.,\u2026Murayama, S. (2017). Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study. PLoS One, 12(2), e0171524. https:\/\/doi.org\/10.1371\/journal.pone.0171524.","DOI":"10.1371\/journal.pone.0171524"},{"issue":"11","key":"10.1016\/j.bbi.2025.106138_b0240","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.bbi.2025.106138_b0245","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/alz.13770","article-title":"Minimal clinically important difference in Alzheimer's disease: Rapid review","volume":"20","author":"Muir","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.bbi.2025.106138_b0250","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JAD-210608","article-title":"Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease","volume":"84","author":"Mulak","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bbi.2025.106138_b0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40659-022-00404-3","article-title":"Inflammation context in Alzheimer's disease, a relationship intricate to define","volume":"55","author":"Novoa","year":"2022","journal-title":"Biol. Res."},{"key":"10.1016\/j.bbi.2025.106138_b0260","unstructured":"Oksanen, J., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O'Hara, R. B.,\u2026Wagner, H. (2012). vegan: Community Ecology Package . In. Software http:\/\/CRAN.R-project.org\/package=vegan."},{"issue":"24","key":"10.1016\/j.bbi.2025.106138_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413269","article-title":"Anthranilic Acid-G-Protein coupled Receptor109A-cytosolic Phospholipase A2-myelin-Cognition Cascade: a New Target for the Treatment\/Prevention of Cognitive Impairment in Schizophrenia, Dementia, and Aging","volume":"25","author":"Oxenkrug","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.106138_b0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2022.05.006","article-title":"Causal effects of circulating cytokine concentrations on risk of Alzheimer's disease and cognitive function","volume":"104","author":"Pagoni","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2025.106138_b0280","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41598-024-84780-8","article-title":"Protection of Alzheimer's disease progression by a human-origin probiotics cocktail","volume":"15","author":"Prajapati","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.106138_b0285","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07299-8","article-title":"[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study","author":"Quattrini","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"10.1016\/j.bbi.2025.106138_b0290","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4103\/1673-5374.332127","article-title":"Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease","volume":"17","author":"Roda","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"5","key":"10.1016\/j.bbi.2025.106138_b0295","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2009.05.002","article-title":"Reduced hippocampal glutamate in Alzheimer disease","volume":"32","author":"Rupsingh","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2025.106138_b0300","doi-asserted-by":"crossref","unstructured":"Sekiya, M., Sakakibara, Y., Hirota, Y., Ito, N., Chikamatsu, S., Takei, K.,\u2026Iijima, K. M. (2024). Decreased plasma nicotinamide and altered NAD. Neurobiol Dis, 202, 106694. https:\/\/doi.org\/10.1016\/j.nbd.2024.106694.","DOI":"10.1016\/j.nbd.2024.106694"},{"issue":"7","key":"10.1016\/j.bbi.2025.106138_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11071825","article-title":"Microbial-Derived Tryptophan Metabolites and their Role in Neurological Disease: Anthranilic Acid and Anthranilic Acid Derivatives","volume":"11","author":"Shaw","year":"2023","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.bbi.2025.106138_b0310","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4088\/JCP.08m04828","article-title":"Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease","volume":"70","author":"Siddique","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106138_b0315","doi-asserted-by":"crossref","unstructured":"Sim, M. A., Liao, Y., Chan, S. P., Tan, E. S. J., Kan, C. N., Chong, J. R.,\u2026Lai, M. K. P. (2025). Low serum serotonin is associated with functional decline, mild behavioural impairment and brain atrophy in dementia-free subjects. Brain Commun, 7(1), fcaf005. https:\/\/doi.org\/10.1093\/braincomms\/fcaf005.","DOI":"10.1093\/braincomms\/fcaf005"},{"key":"10.1016\/j.bbi.2025.106138_b0320","doi-asserted-by":"crossref","unstructured":"Soca\u0142a, K., Doboszewska, U., Szopa, A., Serefko, A., W\u0142odarczyk, M., Zieli\u0144ska, A.,\u2026Wla\u017a, P. (2021). The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res, 172, 105840. https:\/\/doi.org\/10.1016\/j.phrs.2021.105840.","DOI":"10.1016\/j.phrs.2021.105840"},{"issue":"3","key":"10.1016\/j.bbi.2025.106138_b0325","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","article-title":"The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a critical Review","volume":"56","author":"Sochocka","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.bbi.2025.106138_b0330","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1080\/1028415X.2021.1991556","article-title":"DP189 prevents cognitive dysfunction in D-galactose\/AlCl","volume":"25","author":"Song","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbi.2025.106138_b0335","doi-asserted-by":"crossref","unstructured":"Sun, J., Xu, J., Yang, B., Chen, K., Kong, Y., Fang, N.,\u2026Liu, J. (2020). Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate. Mol Nutr Food Res, 64(2), e1900636. https:\/\/doi.org\/10.1002\/mnfr.201900636.","DOI":"10.1002\/mnfr.201900636"},{"key":"10.1016\/j.bbi.2025.106138_b0340","doi-asserted-by":"crossref","unstructured":"Sun, M., Bao, W., Huang, C., Xia, Z., Zhang, C., Wang, G.,\u2026Bao, X. (2021). A Novel Probiotic Formula, BIOCG, Protects Against Alzheimer's-Related Cognitive Deficits via Regulation of Dendritic Spine Dynamics. Curr Alzheimer Res, 18(7), 558-572. https:\/\/doi.org\/10.2174\/1567205018666211022091110.","DOI":"10.2174\/1567205018666211022091110"},{"key":"10.1016\/j.bbi.2025.106138_b0345","doi-asserted-by":"crossref","unstructured":"Tamtaji, O. R., Heidari-Soureshjani, R., Mirhosseini, N., Kouchaki, E., Bahmani, F., Aghadavod, E.,\u2026Asemi, Z. (2019). Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial. Clin Nutr, 38(6), 2569-2575. https:\/\/doi.org\/10.1016\/j.clnu.2018.11.034.","DOI":"10.1016\/j.clnu.2018.11.034"},{"key":"10.1016\/j.bbi.2025.106138_b0350","doi-asserted-by":"crossref","unstructured":"Ton, A. M. M., Campagnaro, B. P., Alves, G. A., Aires, R., C\u00f4co, L. Z., Arpini, C. M.,\u2026Vasquez, E. C. (2020). Oxidative Stress and Dementia in Alzheimer's Patients: Effects of Synbiotic Supplementation. Oxid Med Cell Longev, 2020, 2638703. https:\/\/doi.org\/10.1155\/2020\/2638703.","DOI":"10.1155\/2020\/2638703"},{"key":"10.1016\/j.bbi.2025.106138_b0360","doi-asserted-by":"crossref","unstructured":"Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bj\u00f8rklund, G.,\u2026Pascale, A. (2022). The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment. Nutrients, 14(3). https:\/\/doi.org\/10.3390\/nu14030668.","DOI":"10.3390\/nu14030668"},{"key":"10.1016\/j.bbi.2025.106138_b0365","doi-asserted-by":"crossref","unstructured":"Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C.,\u2026Rey, F. E. (2017). Gut microbiome alterations in Alzheimer's disease. Sci Rep, 7(1), 13537. https:\/\/doi.org\/10.1038\/s41598-017-13601-y.","DOI":"10.1038\/s41598-017-13601-y"},{"key":"10.1016\/j.bbi.2025.106138_b0370","doi-asserted-by":"crossref","unstructured":"Walker, K. A., Chen, J., Zhang, J., Fornage, M., Yang, Y., Zhou, L.,\u2026Coresh, J. (2021). Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat Aging, 1(5), 473-489. https:\/\/doi.org\/10.1038\/s43587-021-00064-0.","DOI":"10.1038\/s43587-021-00064-0"},{"key":"10.1016\/j.bbi.2025.106138_b0375","doi-asserted-by":"crossref","unstructured":"Whiley, L., Chappell, K. E., D'Hondt, E., Lewis, M. R., Jim\u00e9nez, B., Snowden, S. G.,\u2026consortium, A. (2021). Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease. Alzheimers Res Ther, 13(1), 20. https:\/\/doi.org\/10.1186\/s13195-020-00741-z.","DOI":"10.1186\/s13195-020-00741-z"},{"issue":"1","key":"10.1016\/j.bbi.2025.106138_b0380","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s41043-025-00816-3","article-title":"Effect of probiotics on cognitive function and cardiovascular risk factors in mild cognitive impairment and Alzheimer's disease: an umbrella meta-analysis","volume":"44","author":"Xiao","year":"2025","journal-title":"J. Health Popul. Nutr."},{"key":"10.1016\/j.bbi.2025.106138_b0385","doi-asserted-by":"crossref","unstructured":"Xiao, J., Katsumata, N., Bernier, F., Ohno, K., Yamauchi, Y., Odamaki, T.,\u2026Kaneko, T. (2020). Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis, 77(1), 139-147. https:\/\/doi.org\/10.3233\/JAD-200488.","DOI":"10.3233\/JAD-200488"},{"key":"10.1016\/j.bbi.2025.106138_b0390","doi-asserted-by":"crossref","unstructured":"Yu, D., Du, J., Pu, X., Zheng, L., Chen, S., Wang, N.,\u2026Shen, B. (2021). The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis. Front Cell Infect Microbiol, 11, 763507. https:\/\/doi.org\/10.3389\/fcimb.2021.763507.","DOI":"10.3389\/fcimb.2021.763507"},{"issue":"11","key":"10.1016\/j.bbi.2025.106138_b0395","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/acs.jafc.3c00652","article-title":"HNXY26M4 Attenuates Cognitive Deficits and Neuroinflammation by Regulating the Gut-Brain Axis in APP\/PS1 mice","volume":"71","author":"Zhu","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbi.2025.106138_b0400","doi-asserted-by":"crossref","unstructured":"Zhuang, Z. Q., Shen, L. L., Li, W. W., Fu, X., Zeng, F., Gui, L.,\u2026Wang, Y. J. (2018). Gut Microbiota is Altered in Patients with Alzheimer's Disease. J Alzheimers Dis, 63(4), 1337-1346. https:\/\/doi.org\/10.3233\/JAD-180176.","DOI":"10.3233\/JAD-180176"},{"issue":"6","key":"10.1016\/j.bbi.2025.106138_b0405","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics is Associated with Unique Host and Microbiome Features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2025.106138_b0410","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcdb.2022.03.013","article-title":"Impairments of glutamatergic synaptic transmission in Alzheimer's disease","volume":"139","author":"Zott","year":"2023","journal-title":"Semin. Cell Dev. Biol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125003800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125003800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:53:03Z","timestamp":1773273183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":79,"alternative-id":["S0889159125003800"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106138","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota-gut-brain axis dysregulation in Alzheimer\u2019s disease and its modulation through probiotic supplementation","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106138"}}